# EDGAR Filing Document

**Accession Number:** 0001583977
**File Stem:** 0001583977-25-000010
**Filing Date:** 2025-8
**Character Count:** 23860
**Document Hash:** 6a60adddb589018f726ef58cecd84882
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001583977-25-000010.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001583977-25-000010

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cormorant Asset Management, LP
- **CENTRAL INDEX KEY:** 0001583977

**ORGANIZATION NAME:**
- **EIN:** 462108927
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-15949
- **FILM NUMBER:** 251276959

**BUSINESS ADDRESS:**
- **STREET 1:** 200 CLARENDON STREET
- **STREET 2:** 52ND FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 857-702-0388

**MAIL ADDRESS:**
- **STREET 1:** 200 CLARENDON STREET
- **STREET 2:** 52ND FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Cormorant Asset Management, LLC
- **DATE OF NAME CHANGE:** 20130807

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001583977

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Cormorant Asset Management, LP

**Address:** 200 Clarendon Street, Boston, MA 02116

**Telephone number:** (857) 702-0370

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-15949

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                        | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                 | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ABIVAX SA                             | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1893732 |                0 | FOR         |                                  1893732 | FOR                         |  |
| ABIVAX SA                             | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1893732 |                0 | FOR         |                                  1893732 | FOR                         |  |
| ARCELLX, INC.                         | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         550252 |                0 | FOR         |                                   550252 | FOR                         |  |
| ARCUTIS BIOTHERAPEUTICS, INC.         | 03969K108 | 06/12/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         440817 |                0 | FOR         |                                   440817 | FOR                         |  |
| AVIDITY BIOSCIENCES, INC.             | 05370A108 | 06/10/2025     | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         124508 |                0 | FOR         |                                   124508 | FOR                         |  |
| AXSOME THERAPEUTICS, INC.             | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          23690 |                0 | FOR         |                                    23690 | FOR                         |  |
| BIOHAVEN LTD                          | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          10000 |                0 | FOR         |                                    10000 | FOR                         |  |
| BRIDGEBIO PHARMA, INC.                | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         711304 |                0 | FOR         |                                   711304 | FOR                         |  |
| CENTESSA PHARMACEUTICALS PLC          | 152309100 | 06/20/2025     | To receive and approve, on an advisory basis, the Company's U.K. statutory directors' remuneration report for the financial year ended December 31, 2024 (other than the Director's Remuneration Policy which is set on pages A-3 to A-25 of the director's remuneration report), which is set forth as Annex A to the attached proxy statement. | SECTION 14A SAY-ON-PAY VOTES |        2043843 |                0 | FOR         |                                  2043843 | FOR                         |  |
| CENTESSA PHARMACEUTICALS PLC          | 152309100 | 06/20/2025     | To receive and approve the Directors' Remuneration Policy as set out on pages A-3 to A-25 of the Company's UK statutory directors' remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the attached proxy statement, which will take effect immediately after the end of the AGM.               | SECTION 14A SAY-ON-PAY VOTES |        2043843 |                0 | FOR         |                                  2043843 | FOR                         |  |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | 21833P301 | 05/15/2025     | Approval, on an advisory basis, of the executive compensation of the Company's named executive officers.                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        1112072 |                0 | FOR         |                                  1112072 | FOR                         |  |
| CRINETICS PHARMACEUTICALS INC.        | 22663K107 | 06/11/2025     | To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         134185 |                0 | FOR         |                                   134185 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC             | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        3572067 |                0 | FOR         |                                  3572067 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC             | 28036F105 | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        3572067 |                0 | 1 YEAR      |                                  3572067 | FOR                         |  |
| EYEPOINT PHARMACEUTICALS, INC.        | 30233G209 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the accompanying proxy statement.                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1875619 |                0 | FOR         |                                  1875619 | FOR                         |  |
| EYEPOINT PHARMACEUTICALS, INC.        | 30233G209 | 06/18/2025     | To vote, on an advisory basis, on the frequency of advisory stockholder votes on the compensation paid to our named executive officers.                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |        1875619 |                0 | 1 YEAR      |                                  1875619 | FOR                         |  |
| INSMED INCORPORATED                   | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          61665 |                0 | FOR         |                                    61665 | FOR                         |  |
| JANUX THERAPEUTICS, INC.              | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         898076 |                0 | FOR         |                                   898076 | FOR                         |  |
| JANUX THERAPEUTICS, INC.              | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         898076 |                0 | 1 YEAR      |                                   898076 | FOR                         |  |
| KORRO BIO, INC.                       | 500946108 | 06/11/2025     | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers.                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         243362 |                0 | FOR         |                                   243362 | FOR                         |  |
| KORRO BIO, INC.                       | 500946108 | 06/11/2025     | Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         243362 |                0 | 1 YEAR      |                                   243362 | FOR                         |  |
| MERUS N.V.                            | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         634954 |                0 | FOR         |                                   634954 | FOR                         |  |
| MOONLAKE IMMUNOTHERAPEUTICS           | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        7514392 |                0 | FOR         |                                  7514392 | FOR                         |  |
| NEWAMSTERDAM PHARMA COMPANY N.V.      | N62509109 | 06/04/2025     | Non-binding, advisory vote to approve the 2024 compensation of named executive officers.                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        1504856 |                0 | FOR         |                                  1504856 | FOR                         |  |
| NEWAMSTERDAM PHARMA COMPANY N.V.      | N62509109 | 06/04/2025     | Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        1504856 |                0 | 1 YEAR      |                                  1504856 | FOR                         |  |
| PLIANT THERAPEUTICS, INC.             | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        2367310 |                0 | FOR         |                                  2367310 | FOR                         |  |
| PRAXIS PRECISION MEDICINES, INC.      | 74006W207 | 06/26/2025     | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.                      | SECTION 14A SAY-ON-PAY VOTES |        1446372 |                0 | FOR         |                                  1446372 | FOR                         |  |
| RHYTHM PHARMACEUTICALS, INC.          | 76243J105 | 09/18/2024     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         341964 |                0 | FOR         |                                   341964 | FOR                         |  |
| STOKE THERAPEUTICS, INC.              | 86150R107 | 06/03/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         254161 |                0 | FOR         |                                   254161 | FOR                         |  |
| STOKE THERAPEUTICS, INC.              | 86150R107 | 06/03/2025     | To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         254161 |                0 | 1 YEAR      |                                   254161 | FOR                         |  |
| TARSUS PHARMACEUTICALS, INC.          | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         146863 |                0 | FOR         |                                   146863 | FOR                         |  |
| TARSUS PHARMACEUTICALS, INC.          | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         146863 |                0 | 1 YEAR      |                                   146863 | FOR                         |  |
| UROGEN PHARMA LTD                     | M96088105 | 08/06/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1469350 |                0 | FOR         |                                  1469350 | FOR                         |  |
| VAXCYTE, INC.                         | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          90288 |                0 | FOR         |                                    90288 | FOR                         |  |
| VYNE THERAPEUTICS INC.                | 92941V308 | 12/12/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1394336 |                0 | FOR         |                                  1394336 | FOR                         |  |
| VYNE THERAPEUTICS INC.                | 92941V308 | 12/12/2024     | To indicate, on an advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        1394336 |                0 | 1 YEAR      |                                  1394336 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Cormorant Asset Management, LP

**By (Signature):** Neb Obradovic

**By (Printed Signature):** Neb Obradovic

**By (Title):** CCO

**Date:** 08/29/2025